A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2001
11/15/2001	WO2001085202A2 Electroporation for introduction of molecules into cells
11/15/2001	WO2001085201A2 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
11/15/2001	WO2001085141A1 β-GLUCANS ENCAPSULATED IN LIPOSOMES
11/15/2001	WO2001084938A1 Method of inducing apoptosis with melothria indica lou extract
11/15/2001	WO2001076627A8 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
11/15/2001	WO2001049729A8 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
11/15/2001	WO2001038350A3 85kDa NEISSERIAL ANTIGEN
11/15/2001	WO2001036656A3 A complex between hyaluronic acid and a biomolecule and its use
11/15/2001	WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001	WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001	WO2001019974A3 Recombinant microorganisms
11/15/2001	WO2001017555A3 Food grade saponins as oral adjuvants
11/15/2001	WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001	WO2001011065A3 Hepatitis a virus clones adapted for growth in agmk cells
11/15/2001	WO2001006756A3 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes
11/15/2001	WO2001003717A3 Methods of inducing cell death
11/15/2001	WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001	WO2000075352A3 Hcv/bvdv chimeric genomes and uses thereof
11/15/2001	WO2000058365A9 Specific binding proteins for treating canine allergy
11/15/2001	WO2000050584A3 Methods and compositions for enhancing in vivo gene delivery/expression
11/15/2001	US20010041788 Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
11/15/2001	US20010041183 Immediate early 63 protein; side effect reduction
11/15/2001	US20010041182 Stable activity antioxidant provitamin such as l-ascorbic acid-2-phosphate and alpha-tocopheryl phosphate
11/15/2001	US20010041181 Relieving pain related to muscle activity or contracture, antispasmodic
11/15/2001	US20010041180 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
11/15/2001	US20010041179 Immunosuppression with monoclonal antibodies specific for interleukin-2 receptor
11/15/2001	US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001	US20010041177 Biomarker molecule CD163, antibody complex
11/15/2001	CA2411244A1 Therapeutic pore-forming peptides
11/15/2001	CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	CA2409150A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001	CA2408738A1 Virulence genes, proteins, and their use
11/15/2001	CA2408732A1 Modified es cells and es cell-specific gene
11/15/2001	CA2408632A1 Ph domain-interacting protein
11/15/2001	CA2408594A1 Human monoclonal antibodies to dendritic cells
11/15/2001	CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
11/15/2001	CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408349A1 Method of regulating angiogenesis unsing ryk protein
11/15/2001	CA2408344A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408199A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2001	CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407897A1 Molecular antigen arrays and vaccines
11/15/2001	CA2406644A1 Sentinel virus ii
11/14/2001	EP1154019A2 G-protein coupled receptor (HFGAN72X)
11/14/2001	EP1153611A2 Pharmaceutical composition for the treatment of fibrosis
11/14/2001	EP1153136A2 Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
11/14/2001	EP1153035A2 Human lipid-associated proteins
11/14/2001	EP1152773A1 Methods of inactivating pathogens using broad-spectrum pulsed light
11/14/2001	EP1152771A2 Adjuvant and cell maturation agent
11/14/2001	EP1152769A1 Yeast cell wall peptides and antibodies thereto
11/14/2001	EP1152768A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
11/14/2001	EP1152767A2 Method for producing anti-tumor th1 cells
11/14/2001	EP1152752A1 Methods for preventing graft rejection and ischemia-reperfusion injury
11/14/2001	EP0939647B1 Neisseria meningitidis serogroup b glycoconjugates and methods of using the same
11/14/2001	EP0715653B1 Humanised antibodies
11/14/2001	EP0656010B8 Use of peptides causing a immune response for the preparation of medicaments to induce the suppression of the immune reaction.
11/14/2001	EP0652948B1 Development of a vector to target gene expression to the epidermis of transgenic animals
11/14/2001	EP0576471B1 Recombinant virus vectors encoding human papillomavirus proteins
11/14/2001	CN1322251A Mutant human hepatitis B viral strain and uses thepeof
11/14/2001	CN1322250A Peptides derived from attachment (G) protein of respiratory syncytial virus
11/14/2001	CN1322249A Neiseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/14/2001	CN1322244A Tumor necrosis factor-gamma
11/14/2001	CN1321516A Multistrain universal inactivated vaccine for bovine, ovine and porcine foot-and-mouth diseases
11/14/2001	CN1074653C Anti-virus immunological milk
11/13/2001	US6316609 Nucleotide sequence of Escherichia coli pathogenicity islands
11/13/2001	US6316601 Antibodies specific for β6 integrins
11/13/2001	US6316492 Methods for treating or preventing viral infections and associated diseases
11/13/2001	US6316462 Methods of inducing cancer cell death and tumor regression
11/13/2001	US6316444 SRC kinase inhibitor compounds
11/13/2001	US6316420 Immunization against multiple sclerosis with administering to subject a naked dna nucleic acid construct encoding a cytokine
11/13/2001	US6316412 Polypeptides for promoting cell attachment
11/13/2001	US6316408 Methods of use for osetoprotegerin binding protein receptors
11/13/2001	US6316403 Deactivation of factor ix for coagulation inhibition and antiischemic agents
11/13/2001	US6316272 Monitoring binding of cancer modulator; mix protein and modulator, incubate, detect binding of modulator
11/13/2001	US6316258 Inhibiting angiotensin/renin induced generation of transforming growth factor; mix renin with modulator and sample, incubate, evaluate sample for reduced generation of transforming growth factor
11/13/2001	US6316256 Method for protein transfer
11/13/2001	US6316250 Molecular clones producing recombinant DNA antigens of the hantavirus-associated respiratory distress (HARDS)
11/13/2001	US6316243 Viral nucleotide sequences; for the reduction or prevention of viral infection
11/13/2001	US6316239 HKABY60 kinase family polypeptides
11/13/2001	US6316237 Respiratory nitrate reductase alpha subunit
11/13/2001	US6316227 Dna sequence encoding a composite heavy chain of a recombinant antibody molecule that specifically binds human interleukin-5 antigen
11/13/2001	US6316219 Compounds
11/13/2001	US6316213 Methods for the early diagnosis of ovarian, breast and lung cancer
11/13/2001	US6316209 Methods for diabetes susceptibility assessment in asymptomatic patients
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6316199 Arginase II
11/13/2001	US6316183 Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)
11/13/2001	US6316007 Combined physical and immunotherapy for cancer
11/13/2001	US6316005 Borrelia burgdorferi bacterin
11/13/2001	US6316004 To stimulate the growth of animal
11/13/2001	US6316003 Presenting to the cell an extracellular fusion protein consisting of a cargo moiety and a transport moiety and allowing transport moiety-dependent intracellular delivery of the fusion protein
11/13/2001	US6316000 For preventing the development of a parasite in an arthropod;for immunization

1 ... 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 ... 1823